Wealthfront’s GSK GSK Stock Holding History

Wealthfront’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4	Closed	–	–	591
2015 Q3	$0	Sell	4 -303	-99%	-$15.8K	﹤0.01%	1326
2015 Q2	$16K	Buy	+307	New	+$17.3K	﹤0.01%	701
2014 Q4	–	Sell	-21	Closed	-$1K	–	795
2014 Q3	$1K	Sell	21 -75	-78%	-$4.6K	﹤0.01%	641
2014 Q2	$7K	Buy	+96	New	+$6.5K	﹤0.01%	525

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wealthfront's GSK Position: Q4 2015 in Review

Wealthfront sold out of GSK (GSK) in Q4 2015, closing a stake of 4 shares.

Wealthfront first reported a position in GSK in Q2 2014 and held it in 4 quarters. The position peaked at $16K in Q2 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Wealthfront reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
Wealthfront sold 4 GSK shares in Q4 2015.
Wealthfront first reported a position in GSK in Q2 2014 and held it in 4 quarters.
Wealthfront's GSK position peaked at $16K in Q2 2015.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.